Review
These authors share last author position.
Received: 20 April 2009; Accepted: 4 May 2009
10.1002/emmm.200900024 About DOI
PINK1 function in health and disease |
| Emma Deas, Helene Plun-Favreau, Nicholas W. Wood * |
| Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK |
| email: Nicholas W. Wood (n.wood@ion.ucl.ac.uk) |
*Correspondence to Nicholas W. Wood, Tel: (+44) 207 837 3611 ex 4255; Fax: (+44) 207 278 5616
These authors share last author position.| Keywords |
| calcium signalling mitochondria oxidative stress PINK1 |
| Abstract |
| The role of mitochondria in sporadic Parkinson's disease (PD) has been debated for a little over 20 years since the description of complex I deficiency in the substantia nigra pars compacta (SNpc) of PD patients. However, the identification of recessive pathogenic mutations in the pink1 gene in familial PD cases firmly re-ignited interest in the pathophysiology of mitochondria in PD. PINK1 is a putative mitochondrial serine/threonine kinase, which protects cells against oxidative stress induced apoptosis. The mechanism by which this is achieved and the effect of the pathogenic mutations has been an area of intensive research over the past five years. Significant progress has been made and, in this review, we summarize the physiological roles that have been assigned to PINK1 and the potential mechanisms behind pathogenesis. |
Received: 20 April 2009; Accepted: 4 May 2009
| Digital Object Identifier (DOI) |
10.1002/emmm.200900024 About DOI
Journal Menu
-
Authors & Referees
